Our meta‐ analysis showed beneficial effects  of statin use  on reducing inflammatory markers in patients with MetS and related disorders
& NA ; Current evidence suggests that statin use decreases the incidence of cardiovascular diseases ( CVD ) through reducing LDL cholesterol and decreasing inflammation .
Metabolic syndrome ( MetS ) is usually associated with increased inflammatory markers and increased risk of CVD .
Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
To determine the effects of statins on vascular function , inflammation , and and rogen levels in women with polycystic ovary syndrome ( PCOS ) , we r and omized 20 women with PCOS who had low-density lipoprotein cholesterol levels > 100 mg/dL to  atorvastatin ( 40 mg/day ) or  placebo  for 6 weeks and found that atorvastatin reduced and rogen levels , biomarkers of inflammation , and blood pressure ; increased insulin levels and brachial artery conductance during reactive hyperemia ; and failed to improve brachial artery flow-mediated dilation . We conclude that until additional studies demonstrate a clear risk-to-benefit ratio favoring statin therapy in PCOS , statins should only be used in women with PCOS who meet current indications for statin treatment
Our meta‐ analysis showed beneficial effects  of statin use  on reducing inflammatory markers in patients with MetS and related disorders
& NA ; Current evidence suggests that statin use decreases the incidence of cardiovascular diseases ( CVD ) through reducing LDL cholesterol and decreasing inflammation .
Metabolic syndrome ( MetS ) is usually associated with increased inflammatory markers and increased risk of CVD .